Economics Analytics Enterprises
Population:
12 692 466
Enterprises:
2255
Average salary:
1 483 USD
Population:
8 908 081
Enterprises:
841 000
Average salary:
6722 USD
Population:
8 398 748
Enterprises:
220 000
Average salary:
9 470 USD
Population:
13 942 024
Enterprises:
660 000
Average salary:
2967
Population:
9 668 465
Enterprises:
6 530 000
Average salary:
3908 USD

An article on the effectiveness and safety of Sputnik V was published in Nature

94 topic: Health, trends, Vaccine

Nature writes that many of the scientists' concerns about Sputnik V were eliminated at the publication stage of phase III trials. "The results showed that the vaccine is 91.6% effective in preventing COVID-19 and 100% effective in preventing severe infection."

The publication notes that Sputnik V is similar to AstraZeneca and Johnson & Johnson but the Russian vaccine uses different adenoviruses, which makes it more effective.

In 70 countries where Sputnik V is used, no serious side effects have been recorded, for example, death from thrombosis.

 

 

 

Sign in or login via our site or social networks to commentory.